Many people choose low-carbohydrate diets hoping to reduce inflammation. Inflammation is a body process that can lead to heart disease and other health problems. Researchers looked at how two common diets compare. They compared low-carb diets to low-fat diets in a group of 2222 adults. The study tracked specific proteins in the blood that signal inflammation. These include interleukin-6, C-reactive protein, and others like adiponectin and leptin. The participants followed their chosen diets for five and a half months. The results showed no significant difference between the two approaches. Low-carb diets did not outperform low-fat diets in changing these blood markers. This means both diets may have similar effects on these specific inflammation signals. The study did not report safety issues or side effects for either group. However, the researchers note that future trials should explore nutrient quality and how well people stick to the diet. They also suggest looking at the metabolic status of the participants. This review confirms that for these specific markers, the choice between low-carb and low-fat may not matter much.
Low-carbohydrate diets showed no significant difference versus low-fat diets for inflammatory markers in adults over 5.5 monthsLow-carb diets did not beat low-fat diets on inflammation markers in adults
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This systematic review and meta-analysis compared low-carbohydrate (LC) diets against low-fat (LF) diets in an adult population. The analysis included 2222 participants and assessed changes in concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-alpha, adiponectin, leptin, and resistin. The follow-up duration was 5.5 months.
The meta-analysis found no significant difference between the two dietary approaches for interleukin-6, with a standardized mean difference of -0.01 and a 95% CI of -0.12 to 0.09. Similarly, C-reactive protein showed no significant difference with an SMD of -0.01 and a 95% CI of -0.11 to 0.09. Tumor necrosis factor-alpha also showed no significant difference with an SMD of -0.03 and a 95% CI of -0.18 to 0.11. Data for adiponectin, leptin, and resistin were not reported for effect size or confidence intervals, yet no significant difference was observed for these markers as well.
Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported. The authors acknowledge that future trials should explore the influence of nutrient quality, adherence, and metabolic status. Consequently, LC diets were not superior to LF diets in modulating the inflammatory and adipokine profiles in adults.